Sanofi announced in late April that it has entered into a collaboration with the Michael J. Fox
Foundation (MJFF) to conduct a clinical trial to assess the safety and tolerability of AVE 8112, a Sanofi phosphodiesterase type 4 (PDE4) inhibitor, in
patients with Parkinson’s disease
Ambry Genetics, a
global leader in clinical diagnostics and genomic services, announced last month the launch of Fluidigm BioMark HD and Access Array System-based genomic
research services
BGI announced May 2 that the genomics organization will work with George
Mason University (GMU), the Massachusetts Eye and Ear Infirmary and the University of Oklahoma Health Sciences Center (OUHSC) to sequence 100 human
adenoviruses gathered from researchers globally, including ones that cause respiratory, gastrointestinal and ocular diseases
AMRI was recently selected by Biota Holdings Ltd. to further develop and manufacture the influenza antiviral CS8958
(laninamivir), a second-generation, long-acting neuraminidase inhibitor
The new guidelines will have a wide-reaching financial impact on the life-
science industry by creating serious administrative and operational challenges that will have to be addressed relatively quickly.
How do we make
decisions? Do we analyze Democrats and Republicans with respect to their overall “comparative effectiveness,” or is it their “comparative ineffectiveness”
that influences our thinking?
QIAGEN announced May 3 that it has joined the
Point-of-Care Diagnostics (POC Dx) Initiative led by the Bill & Melinda Gates Foundation and Grand Challenges Canada
He’s not climbing into his DeLorean and punching in a destination far into the past, but actor and Parkinson’s disease advocate Michael J. Fox
surprised many recently when he told ABC News reporter Diane Sawyer that stem cell research may not be the future of treatments or a cure for this
debilitating disease.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.